Tuning drug release from polyoxazoline-drug conjugates
J. Milton Harris(University of Alabama in Huntsville), Lars Nordstierna(Chalmers University of Technology), Kunsang Yoon, Bekir Dizman, Randall W. Moreadith(The University of Texas Southwestern Medical Center), Rebecca Weimer, Zhihao Fang(Xi'an University of Architecture and Technology), Tacey X. Viegas(Mirna Therapeutics (United States)), Michael D. Bentley(Minnesota State University, Mankato)
Cited by 50
Related Papers
Polyoxazoline: Chemistry, Properties, and Applications in Drug Delivery
|Bioconjugate Chemistry|2011|424
Cardioprotective effects of 70-kDa heat shock protein in transgenic mice.
|Proceedings of the National Academy of Sciences|1996|249
Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications
|European Polymer Journal|2016|175
Towards the Automatic Anime Characters Creation with Generative Adversarial Networks
|arXiv (Cornell University)|2017|136